Allowing such medications as options could lead to significant savings from improved health, writes Kelley Koch.

The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

US-based pharmaceutical company Eli Lilly is planning to launch Mounjaro, an anti-diabetes and weight loss ... a prescription-based medication that has to be injected once a week.

Rocketing demand, legal disputes, and the future of weight loss were all spurred by a new class of anti-obesity medications.

For example, there are significant differences in how well people respond to anti-obesity or anti-diabetes drugs, and we hope ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk.